Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Bacterial biofilms: a common cause of persistent infections.

Costerton JW, Stewart PS, Greenberg EP.

Science. 1999 May 21;284(5418):1318-22. Review.

PMID:
10334980
2.

Biofilms: microbes and disease.

Aparna MS, Yadav S.

Braz J Infect Dis. 2008 Dec;12(6):526-30. Review.

3.
4.

Pseudomonas aeruginosa chronic colonization in cystic fibrosis patients.

Murray TS, Egan M, Kazmierczak BI.

Curr Opin Pediatr. 2007 Feb;19(1):83-8. Review.

PMID:
17224667
5.

Shifting paradigms in Pseudomonas aeruginosa biofilm research.

Tart AH, Wozniak DJ.

Curr Top Microbiol Immunol. 2008;322:193-206. Review.

PMID:
18453277
6.

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth.

Høiby N, Krogh Johansen H, Moser C, Song Z, Ciofu O, Kharazmi A.

Microbes Infect. 2001 Jan;3(1):23-35. Review.

PMID:
11226851
7.

Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways.

Hassett DJ, Sutton MD, Schurr MJ, Herr AB, Caldwell CC, Matu JO.

Trends Microbiol. 2009 Mar;17(3):130-8. doi: 10.1016/j.tim.2008.12.003. Epub 2009 Feb 21. Review.

PMID:
19231190
9.

Pseudomonas aeruginosa biofilms in cystic fibrosis.

Høiby N, Ciofu O, Bjarnsholt T.

Future Microbiol. 2010 Nov;5(11):1663-74. doi: 10.2217/fmb.10.125. Review.

PMID:
21133688
10.

[Foreign body infections--biofilms and quorum sensing].

Høiby N, Johansen HK, Ciofu O, Jensen PØ, Bjarnsholt T, Givskov M.

Ugeskr Laeger. 2007 Nov 26;169(48):4163-6. Review. Danish.

PMID:
18211783
11.

Antimicrobial resistance, respiratory tract infections and role of biofilms in lung infections in cystic fibrosis patients.

Ciofu O, Tolker-Nielsen T, Jensen PØ, Wang H, Høiby N.

Adv Drug Deliv Rev. 2015 May;85:7-23. doi: 10.1016/j.addr.2014.11.017. Epub 2014 Dec 2. Review.

PMID:
25477303
12.

Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets.

Hassett DJ, Cuppoletti J, Trapnell B, Lymar SV, Rowe JJ, Yoon SS, Hilliard GM, Parvatiyar K, Kamani MC, Wozniak DJ, Hwang SH, McDermott TR, Ochsner UA.

Adv Drug Deliv Rev. 2002 Dec 5;54(11):1425-43. Review.

PMID:
12458153
13.

The clinical impact of bacterial biofilms.

Høiby N, Ciofu O, Johansen HK, Song ZJ, Moser C, Jensen PØ, Molin S, Givskov M, Tolker-Nielsen T, Bjarnsholt T.

Int J Oral Sci. 2011 Apr;3(2):55-65. doi: 10.4248/IJOS11026. Review.

14.

[Bacteria and biofilm in respiratory tract infections].

Drago L.

Infez Med. 2009 Jul;17 Suppl 2:3-9. Review. Italian.

15.

Bugs, biofilms, and resistance in cystic fibrosis.

Davies JC, Bilton D.

Respir Care. 2009 May;54(5):628-40. Review.

16.

Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.

Costerton JW.

Trends Microbiol. 2001 Feb;9(2):50-2. Review.

PMID:
11173226
17.

New antimicrobials in the management of cystic fibrosis.

Høiby N.

J Antimicrob Chemother. 2002 Feb;49(2):235-8. Review. No abstract available.

18.

Persistent infections and immunity in cystic fibrosis.

Yu H, Head NE.

Front Biosci. 2002 Feb 1;7:d442-57. Review.

PMID:
11815305
19.

Pseudomonas aeruginosa biofilm infections: from molecular biofilm biology to new treatment possibilities.

Tolker-Nielsen T.

APMIS Suppl. 2014 Dec;(138):1-51. doi: 10.1111/apm.12335. Review.

PMID:
25399808
20.

Interference of Pseudomonas aeruginosa signalling and biofilm formation for infection control.

Bjarnsholt T, Tolker-Nielsen T, Høiby N, Givskov M.

Expert Rev Mol Med. 2010 Apr 7;12:e11. doi: 10.1017/S1462399410001420. Review.

PMID:
20370936
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk